Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:InvoX_Pharma
|
| gptkbp:acquisitionYear |
2022
|
| gptkbp:focusesOn |
immuno-oncology
bispecific antibodies |
| gptkbp:foundedYear |
2006
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
F-star
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
gptkb:FS118
gptkb:FS222 |
| gptkbp:platform |
modular antibody technology
|
| gptkbp:stockSymbol |
gptkb:FSTX
|
| gptkbp:website |
https://www.f-star.com/
|
| gptkbp:bfsParent |
gptkb:Jean-François_Formela
|
| gptkbp:bfsLayer |
7
|